6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: August 10, 2023
Period of Report: August 10, 2023
Accession Number: 0001213900-23-065316

View Document ↗ View on SEC.gov ↗